QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:QIA - NL0015002CX3 - Common Stock
40.405 EUR
-0.58 (-1.42%)
QIA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 19 industry peers in the Life Sciences Tools & Services industry. QIA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QIA has a decent growth rate and is not valued too expensively. This makes QIA very considerable for quality investing!
1. Profitability
1.1 Basic Checks
QIA had positive earnings in the past year.
QIA had a positive operating cash flow in the past year.
In the past 5 years QIA has always been profitable.
Each year in the past 5 years QIA had a positive operating cash flow.
1.2 Ratios
The Return On Assets of QIA (6.19%) is better than 68.42% of its industry peers.
QIA's Return On Equity of 11.11% is fine compared to the rest of the industry. QIA outperforms 68.42% of its industry peers.
The Return On Invested Capital of QIA (7.44%) is better than 63.16% of its industry peers.
QIA had an Average Return On Invested Capital over the past 3 years of 7.25%. This is below the industry average of 9.25%.
The 3 year average ROIC (7.25%) for QIA is below the current ROIC(7.44%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROIC | 7.44% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
The Profit Margin of QIA (19.58%) is better than 94.74% of its industry peers.
QIA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 27.02%, QIA belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
QIA's Operating Margin has improved in the last couple of years.
QIA has a better Gross Margin (64.10%) than 94.74% of its industry peers.
In the last couple of years the Gross Margin of QIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QIA is destroying value.
The number of shares outstanding for QIA has been reduced compared to 1 year ago.
Compared to 5 years ago, QIA has less shares outstanding
The debt/assets ratio for QIA has been reduced compared to a year ago.
2.2 Solvency
QIA has an Altman-Z score of 3.55. This indicates that QIA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.55, QIA is doing good in the industry, outperforming 68.42% of the companies in the same industry.
The Debt to FCF ratio of QIA is 4.50, which is a neutral value as it means it would take QIA, 4.50 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.50, QIA is doing good in the industry, outperforming 73.68% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that QIA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.45, QIA is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Altman-Z | 3.55 |
ROIC/WACC0.94
WACC7.92%
2.3 Liquidity
QIA has a Current Ratio of 2.60. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.60, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
QIA has a Quick Ratio of 2.30. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.30, QIA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.62% over the past year.
QIA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.40% yearly.
QIA shows a small growth in Revenue. In the last year, the Revenue has grown by 5.32%.
Measured over the past years, QIA shows a small growth in Revenue. The Revenue has been growing by 5.32% on average per year.
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
3.2 Future
QIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.54% yearly.
QIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.12% yearly.
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y9.54%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.12%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.81, QIA is valued on the expensive side.
QIA's Price/Earnings ratio is a bit cheaper when compared to the industry. QIA is cheaper than 68.42% of the companies in the same industry.
QIA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.15.
With a Price/Forward Earnings ratio of 18.08, QIA is valued on the expensive side.
QIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. QIA is cheaper than 68.42% of the companies in the same industry.
QIA is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.22, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.81 | ||
| Fwd PE | 18.08 |
4.2 Price Multiples
QIA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. QIA is cheaper than 68.42% of the companies in the same industry.
QIA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. QIA is cheaper than 73.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.54 | ||
| EV/EBITDA | 13.71 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QIA does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of QIA may justify a higher PE ratio.
PEG (NY)2.32
PEG (5Y)2.36
EPS Next 2Y8.08%
EPS Next 3Y8.5%
5. Dividend
5.1 Amount
With a yearly dividend of 0.52%, QIA is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.70, QIA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, QIA's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.08%
EPS Next 3Y8.5%
FRA:QIA (12/2/2025, 7:00:00 PM)
40.405
-0.58 (-1.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners89.95%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.76B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts74.17
Price Target44.49 (10.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)-0.61%
PT rev (3m)-1.6%
EPS NQ rev (1m)-1.93%
EPS NQ rev (3m)-1.69%
EPS NY rev (1m)0%
EPS NY rev (3m)0.63%
Revenue NQ rev (1m)-1.93%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.81 | ||
| Fwd PE | 18.08 | ||
| P/S | 4.91 | ||
| P/FCF | 21.54 | ||
| P/OCF | 15.47 | ||
| P/B | 2.79 | ||
| P/tB | 12.76 | ||
| EV/EBITDA | 13.71 |
EPS(TTM)2.04
EY5.05%
EPS(NY)2.23
Fwd EY5.53%
FCF(TTM)1.88
FCFY4.64%
OCF(TTM)2.61
OCFY6.46%
SpS8.22
BVpS14.49
TBVpS3.17
PEG (NY)2.32
PEG (5Y)2.36
Graham Number25.79
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROCE | 10.03% | ||
| ROIC | 7.44% | ||
| ROICexc | 10.67% | ||
| ROICexgc | 39.98% | ||
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% | ||
| FCFM | 22.82% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Debt/EBITDA | 2.17 | ||
| Cap/Depr | 97.52% | ||
| Cap/Sales | 8.94% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.76% | ||
| Profit Quality | 116.56% | ||
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 | ||
| Altman-Z | 3.55 |
F-Score8
WACC7.92%
ROIC/WACC0.94
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y9.54%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.12%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.27%
EBIT Next 3Y22.23%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%
QIAGEN N.V. / QIA.DE FAQ
What is the fundamental rating for QIA stock?
ChartMill assigns a fundamental rating of 6 / 10 to QIA.DE.
What is the valuation status of QIAGEN N.V. (QIA.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to QIAGEN N.V. (QIA.DE). This can be considered as Fairly Valued.
How profitable is QIAGEN N.V. (QIA.DE) stock?
QIAGEN N.V. (QIA.DE) has a profitability rating of 7 / 10.
What is the valuation of QIAGEN N.V. based on its PE and PB ratios?
The Price/Earnings (PE) ratio for QIAGEN N.V. (QIA.DE) is 19.81 and the Price/Book (PB) ratio is 2.79.
How financially healthy is QIAGEN N.V.?
The financial health rating of QIAGEN N.V. (QIA.DE) is 8 / 10.